Exane Derivatives Expedia Group, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Expedia Group, Inc. stock. As of the latest transaction made, Exane Derivatives holds 3 shares of EXPE stock, worth $554. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 7,329
99.96%
Holding current value
$554
Previous $1.43 Million
100.0%
% of portfolio
0.0%
Previous 0.44%
Shares
8 transactions
Others Institutions Holding EXPE
# of Institutions
890Shares Held
112MCall Options Held
2.44MPut Options Held
3.1M-
Vanguard Group Inc Valley Forge, PA15.1MShares$2.8 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY9.47MShares$1.75 Billion0.03% of portfolio
-
State Street Corp Boston, MA5.23MShares$967 Million0.03% of portfolio
-
Windacre Partnership LLC Houston, TX4.32MShares$800 Million8.51% of portfolio
-
Jpmorgan Chase & CO New York, NY3.84MShares$711 Million0.05% of portfolio
About Expedia Group, Inc.
- Ticker EXPE
- Exchange NASDAQ
- Sector Consumer Cyclical
- Industry Travel Services
- Shares Outstandng 152,035,008
- Market Cap $28.1B
- Description
- Expedia Group, Inc. operates as an online travel company in the United States and internationally. The company operates through Retail, B2B, and trivago segments. Its brand portfolio include Brand Expedia, a full-service online travel brand with localized websites; Hotels.com for marketing and distributing lodging accommodations; Vrbo, an online...